TransMedics Inc., an Andover, Mass.-based developer of portable life support systems for organ transplants, has withdrawn its registration for an $86.25 million IPO, citing “market conditions.” It haad planned to trade on the Nasdaq under ticker symbol TMDX, with Morgan Stanley serving as lead underwriter.
